Gabapentinoid Use Is Associated With Reduced Occurrence of Hyperactive Delirium in Older Cancer Patients Undergoing Chemotherapy: A Nationwide Retrospective Cohort Study in Japan

医学 四分位间距 谵妄 倾向得分匹配 优势比 危险系数 回顾性队列研究 内科学 置信区间 外科 重症监护医学
作者
Hiroaki Abe,Masahiko Sumitani,Hiroki Matsui,Reo Inoue,Mitsuru Konishi,Kiyohide Fushimi,Kanji Uchida,Hideo Yasunaga
出处
期刊:Anesthesia & Analgesia [Lippincott Williams & Wilkins]
卷期号:135 (2): 362-369 被引量:3
标识
DOI:10.1213/ane.0000000000006093
摘要

BACKGROUND: It is unclear whether gabapentinoids affect the development of delirium. We aimed to determine the association between gabapentinoid use and hyperactive delirium in older cancer patients undergoing chemotherapy. METHODS: We conducted propensity score-matched analyses using data from a nationwide inpatient database in Japan. We included cancer patients with pain ≥70 years of age undergoing chemotherapy between April 2016 and March 2018. Patients receiving gabapentinoids were matched with control patients using propensity scores. The primary outcome was occurrence of hyperactive delirium during hospitalization, and the secondary outcomes were length of hospital stay, in-hospital fractures, and in-hospital mortality. Hyperactive delirium was identified by antipsychotic use or discharge diagnoses from the International Classification of Diseases, 10th Revision. RESULTS: Among 143,132 identified patients (59% men; mean age, 76.3 years), 14,174 (9.9%) received gabapentinoids and 128,958 (90.1%) did not (control group). After one-to-one propensity score matching, 14,173 patients were included in each group. The occurrence of hyperactive delirium was significantly lower (5.2% vs 8.5%; difference in percent, -3.2% [95% confidence interval, -3.8 to -2.6]; odds ratio, 0.60 [0.54-0.66]; P < .001), the median length of hospital stay was significantly shorter (6 days [interquartile range, 3-15] vs 9 days [4-17]; subdistribution hazard ratio, 1.22 [1.19-1.25]; P < .001), and the occurrence of in-hospital mortality was significantly lower in the gabapentinoid group than in the control group (1.3% vs 1.8%; difference in percent, -0.6% [-0.9 to -0.3]; odds ratio, 0.69 [0.57-0.83]; P < .001). Gabapentinoid use was not significantly associated with the occurrence of in-hospital fractures (0.2% vs 0.2%; difference in percent, 0.0% [-0.1 to 0.1]; odds ratio, 1.07 [0.65-1.76]; P = .799). The results of sensitivity analyses using stabilized inverse probability of treatment weighting were consistent with the results of the propensity score-matched analyses. CONCLUSIONS: Our findings suggest that gabapentinoid use is associated with reduced hyperactive delirium in older cancer patients undergoing chemotherapy, with no evidence of an increase in the fracture rate, length of hospital stay, or in-hospital death.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
16爱学术完成签到,获得积分10
1秒前
syvshc的应助被美丽采纳,获得20
1秒前
1秒前
Rainandbow发布了新的文献求助10
1秒前
我是老大的应助被zyy采纳,获得10
1秒前
香蕉觅云的应助被111采纳,获得10
1秒前
molihuakai的应助被呼呼赞采纳,获得10
2秒前
icecream612的应助被dde采纳,获得50
2秒前
777完成签到,获得积分10
2秒前
ww完成签到,获得积分10
3秒前
哈哈哈完成签到,获得积分10
3秒前
obcx发布了新的文献求助10
4秒前
FashionBoy的应助被廾匸采纳,获得10
4秒前
4秒前
烤肉发布了新的文献求助150
5秒前
静候灵归发布了新的文献求助10
5秒前
azen完成签到,获得积分10
5秒前
5秒前
董H完成签到,获得积分10
6秒前
淡然寇完成签到,获得积分10
7秒前
奕奕完成签到 ,获得积分10
7秒前
科研通AI6.2的应助被zyy采纳,获得10
7秒前
banana的应助被Orion采纳,获得10
7秒前
yxy完成签到 ,获得积分10
9秒前
迅速听白完成签到,获得积分10
9秒前
2711发布了新的文献求助10
10秒前
10秒前
淡然寇发布了新的文献求助30
11秒前
天天快乐的应助被FiiisH采纳,获得10
12秒前
领导范儿的应助被zyy采纳,获得10
13秒前
LVYOUQINGDE完成签到,获得积分10
13秒前
陌上花完成签到,获得积分10
14秒前
健忘曼彤发布了新的文献求助10
14秒前
XYZ完成签到 ,获得积分10
14秒前
15秒前
李爱国的应助被可爱的代珊采纳,获得10
15秒前
17秒前
纯真少年完成签到,获得积分10
17秒前
哈哈镜阿姐完成签到,获得积分10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820